The genotype-phenotype association of CYP3A4 and CYP3A5 polymorphisms to midazolam clearance in vivo

被引：0
|
作者：
He, P [1 ]
Court, MH [1 ]
Greenblatt, DJ [1 ]
von Moltke, LL [1 ]
机构：
[1] Tufts Univ, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2004年 / 44卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
103
引用
收藏
页码：1209 / 1209
页数：1
相关论文
共 50 条
  • [21] Analysis of genotype, MRNA and protein expression of CYP3A4 and CYP3A5 in human liver
    Czerwinski, M
    Lyon, K
    Mudra, D
    Madan, A
    van Schaik, R
    Gaedigk, A
    Parkinson, A
    DRUG METABOLISM REVIEWS, 2002, 34 : 149 - 149
  • [22] Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism
    Lin, YS
    Dowling, ALS
    Quigley, SD
    Farin, FM
    Zhang, J
    Lamba, J
    Schuetz, EG
    Thummel, KE
    MOLECULAR PHARMACOLOGY, 2002, 62 (01) : 162 - 172
  • [23] Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel
    K. B. Mirzaev
    K. I. Samsonova
    P. P. Potapov
    D. A. Andreev
    E. A. Grishina
    K. A. Ryzhikova
    D. A. Sychev
    Molecular Biology Reports, 2019, 46 : 4195 - 4199
  • [24] Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel
    Mirzaev, K. B.
    Samsonova, K., I
    Potapov, P. P.
    Andreev, D. A.
    Grishina, E. A.
    Ryzhikova, K. A.
    Sychev, D. A.
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (04) : 4195 - 4199
  • [25] Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel
    Henningsson, A
    Marsh, S
    Loos, WJ
    Karlsson, MO
    Garsa, A
    Mross, K
    Mielke, S
    Viganò, L
    Locatelli, A
    Verweij, J
    Sparreboom, A
    McLeod, HL
    CLINICAL CANCER RESEARCH, 2005, 11 (22) : 8097 - 8104
  • [26] Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates
    Saiz-Rodriguez, Miriam
    Almenara, Susana
    Navares-Gomez, Marcos
    Ochoa, Dolores
    Roman, Manuel
    Zubiaur, Pablo
    Koller, Dora
    Santos, Maria
    Mejia, Gina
    Borobia, Alberto M.
    Rodriguez-Antona, Cristina
    Abad-Santos, Francisco
    BIOMEDICINES, 2020, 8 (04)
  • [27] The relative role of CYP3A4 and CYP3A5 in eplerenone metabolism
    McGraw, Joseph
    Cherney, Mitchell
    Bichler, Katherine
    Gerhardt, Armin
    Nauman, Mirielle
    TOXICOLOGY LETTERS, 2019, 315 : 9 - 13
  • [28] NEW TOOLS TO DIFFERENTIATE CYP3A4 AND CYP3A5 ACTIVITY
    Li, Xiaohai
    Kamenecka, Theodore M.
    Jeso, Valer
    Micalizio, Glen
    Heyward, Scott
    Walker, Gregory S.
    Cameron, Michael D.
    DRUG METABOLISM REVIEWS, 2015, 47 : 70 - 70
  • [29] Differential inhibition of CYP3A4 and CYP3A5 by verapamil.
    Wang, Y
    Jones, DR
    Hall, SD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P16 - P16
  • [30] Functional polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy
    Coto, Eliecer
    Tavira, Beatriz
    Marin, Rafael
    Ortega, Francisco
    Lopez-Larrea, Carlos
    Ruiz-Ortega, Marta
    Ortiz, Alberto
    Diaz, Marta
    Corao, Ana I.
    Alonso, Belen
    Alvarez, Victoria
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 397 (03) : 576 - 579
12345